Adrian Willig
About Adrian Willig
Adrian Willig serves as the Director of Genomic Research at SOPHiA GENETICS, where he has worked since 2019. He holds an MSc and a PhD in Molecular Biology from the University of Geneva, where he also held various research positions prior to his current role.
Work at SOPHiA GENETICS
Adrian Willig serves as the Director of Genomic Research at SOPHiA GENETICS, a position he has held since 2019. In this role, he oversees genomic research initiatives, contributing to the development and application of genomic technologies. Prior to this position, he worked as the Associate Head of the NGS Lab at the same company from 2016 to 2019, where he played a significant role in next-generation sequencing projects. His expertise in genomic research is central to the company's mission of advancing data-driven medicine.
Education and Expertise
Adrian Willig earned both his MSc and PhD in Molecular Biology from the University of Geneva. He completed his MSc from 1999 to 2004 and his PhD from 2005 to 2010. His academic background provides a strong foundation in molecular biology, which supports his research and leadership roles in genomic science. This educational experience has equipped him with the necessary skills to contribute effectively to the field of genomics.
Background
Adrian Willig's professional journey includes various roles in academic and corporate settings. He began his career at the University of Geneva, where he worked as an Assistant from 2004 to 2010 and later as a Research Associate from 2010 to 2011. He also held a position as a Scientist at Philip Morris International for a brief period in 2012. His diverse experiences have shaped his expertise in genomic research and molecular biology.
Previous Positions
Before his current role at SOPHiA GENETICS, Adrian Willig held several positions that contributed to his professional development. He worked as an NGS Expert Scientist at SOPHiA GENETICS from 2014 to 2016, focusing on next-generation sequencing technologies. His earlier experience as a Research Associate at the University of Geneva and as a Scientist at Philip Morris International further enhanced his research capabilities.